fda import alert semaglutide green list Creates of GLP1 Drug Ingredients Approved for Entry in the US FDA launches 'green list' to
Description
All of these, if present or present at high levels can indicate illness or infection, mainly relating to the heart, liver, kidneys & urinary tract

This is not an anti-medication post

The two most promising of these classes to date are the sodium-glucose transport protein 2 inhibitors (SGLT-2i) and glucagon-like peptide-1 (GLP-1) agonists

We're going to hopefully lead by example and have others join us

[DOI] [PMC free article] [PubMed] [Google Scholar] 88.Zhou Y., Li Z., Cao X., Ma H., White P.F., Xu X., Jiang Y., Sun X., Cui Y
